ClinConnect ClinConnect Logo
Search / Trial NCT06721169

Phenol or Laser: Best Minimally Invasive Treatment for Pilonidal Sinus?

Launched by MERSIN UNIVERSITY · Dec 3, 2024

Trial Information

Current as of November 14, 2025

Recruiting

Keywords

Pilonidal Disease, Phenol, Laser Ablation

ClinConnect Summary

This clinical trial is investigating two treatment options for a common condition called pilonidal sinus disease, which often causes pain, itching, and discharge in the area between the buttocks. The goal of the study is to compare the effectiveness of two minimally invasive methods: one that uses a chemical called phenol to help the body heal the sinus, and another that uses laser technology to destroy the sinus tissue. This research is important because it aims to find the best way to treat this condition while minimizing recovery time and discomfort for patients.

To participate in the trial, individuals must be at least 18 years old and have been diagnosed with uncomplicated pilonidal sinus disease. It’s important that they have not received any previous treatments for this condition. Participants will have their medical information recorded and will need to sign consent forms to join the study. Throughout the trial, participants can expect close monitoring and support as they undergo one of the two treatment options being studied. This could be a great opportunity for those suffering from this condition to contribute to important research while exploring new treatment possibilities.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patients aged 18 years and older with pilonidal sinus disease
  • Patients who have not had any previous treatment for pilonidal sinus disease
  • Patients with uncomplicated pilonidal sinus
  • Having been diagnosed with pilonidal sinus disease
  • Patients whose descriptive and clinical characteristics are recorded in their medical files
  • Those who have signed the Informed Voluntary Consent Form/Written Consent Form
  • Exclusion Criteria:
  • Patients who have previously been treated for pilonidal sinus disease
  • Patients with complicated pilonidal sinus disease
  • Patients aged under 18
  • Patients whose descriptive and clinical characteristics are not recorded in their file records
  • Those who have not signed the Informed Voluntary Consent Form/Written Consent Form

About Mersin University

Mersin University is a distinguished academic institution located in Mersin, Turkey, committed to advancing healthcare through innovative research and clinical trials. With a strong emphasis on interdisciplinary collaboration, the university leverages its extensive resources, expert faculty, and state-of-the-art facilities to facilitate groundbreaking studies. Mersin University aims to contribute to the global medical community by fostering the development of new therapies and improving patient outcomes through rigorous scientific inquiry and ethical standards in clinical research.

Locations

Mersin, Turkey

Patients applied

0 patients applied

Trial Officials

Doğuş Parlak, PhD

Study Director

Mersin University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported